Short-acting heparin-based anticoagulant compounds and methods
US11903963B2 · kind B2 · utility
1Cited by
15References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 2018 |
| Grant date | Feb 20, 2024 |
| Priority date | — |
| Expiry date | Mar 12, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Heparin compounds and synthetic heparin analogues having short acting anticoagulant activity are provided. Methods of synthesizing such heparin compounds, including chemoenzymatic pathways using sulfotransferase enzymes are provided. Methods of treating subjects in need of anticoagulant activity are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.